We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Finds Distinct Malaria Parasites Linked to Sickle Cell Trait Protection

By LabMedica International staff writers
Posted on 13 Oct 2026

Malaria remains one of the world’s deadliest infectious diseases and has affected humans throughout recorded history. More...

In regions where malaria is common, human genetics have been shaped by the sickle cell variant, which can cause disease when inherited in two copies but provides protection against malaria when present in one. Understanding how this protective effect works could inform new approaches to prevention. 

Researchers at University of Utah Health (Salt Lake City, UT, USA) and collaborating institutions used high-throughput DNA sequencing to analyze both human genetics and the malaria parasites infecting study participants. The analysis identified a distinct parasite variety associated with people carrying the sickle cell variant. According to the study, these individuals were infected almost exclusively by this parasite type, which may help explain their lower risk of developing malaria-related disease.

The team analyzed genetic data from more than 2,000 people in Mfou, Cameroon, together with the parasites infecting them. Earlier work had identified the unusual parasite strain in rare symptomatic cases among people with the sickle cell variant. The new study expanded the analysis to asymptomatic infections, which were present in approximately three-quarters of the otherwise healthy study population.

People with and without the sickle cell variant had similar overall infection rates, but the parasite genotypes differed between the groups. Those carrying the sickle cell variant were more likely to be infected with one parasite variety, while genetically distinct parasites were more common among people without the variant. Despite comparable rates of infection, people with the sickle cell variant were only one-tenth as likely to develop harmful disease.

The findings were published in Nature Microbiology in a study titled “Sickle cell haemoglobin status shapes malaria parasite genotype in asymptomatic infections.” Institutions represented in the work include University of Utah Health, University of Douala, Centre Pasteur du Cameroun, and University of Bertoua. The findings suggest that malaria reflects an ongoing evolutionary interaction in which human genetic variation and parasite genetic variation may shape each other.

“It’s still kind of surprising that was under the radar. It was hiding in plain sight. People have been looking at this association for a long time, but you have to be able to ask the parasite for it to tell you this,” said Ellen Leffler, PhD, assistant professor of human genetics at University of Utah Health and one of the senior authors of the study.

“This gives us a new dimension to try to understand what determines the outcomes of infection. We hope this will lead to deeper biological understanding of the parasite and of this co-evolutionary system that is quite unique in humans, and ideally to some practical new strategies for tracking or treating infections,” added Leffler.

Related Links
University of Utah Health


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Image: Graphical Abstract (Nagy, G.R., Munkácsy, G., Murmu, A. et al. Beyond the linear genome: how reference bias threatens preventive medicine and geroscience. GeroScience, 2026. https://doi.org/10.1007/s11357-026-02436-z)

Study Shows How Genome Reference Bias Can Mislead Preventive Testing

Whole-genome sequencing is expected to play a growing role in preventive and predictive medicine, but accurate interpretation remains a major diagnostic challenge. The approach requires comparing billions... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: Natera\'s MCED assay analyzes cell-free DNA in blood to screen for multiple cancers (Image Credit: Adobe Stock)

Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

Natera Inc.’s (Austin, TX, USA) multi-cancer early detection (MCED) assay has received Breakthrough Device designation (BDD) from the U.S. Food and Drug Administration (FDA). The assay analyzes cell-free... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.